Overall survival advantage with partial nephrectomy: A bias of observational data?

Cancer

Volumn 119, Issue 16, 2013, Pages 2981-2989

  Shuch, Brian ^a,b   Hanley, Janet ^c   Lai, Julie ^c   Vourganti, Srinivas ^b   Kim, Simon P ^a,d   Setodji, Claude M ^c   Dick, Andrew W ^c   Chow, Wong Ho ^b   Saigal, Chris ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c RAND CORPORATION   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

observational data; partial nephrectomy; radical nephrectomy; selection bias; survival advantage

Indexed keywords

AGED; ARTICLE; CANCER LOCALIZATION; CANCER SPECIFIC SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEPHRECTOMY; NON MUSCLE INVASIVE BLADDER CANCER; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADICAL NEPHRECTOMY; SURVIVAL TIME; TUMOR VOLUME;

EID: 84881481387     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28141     Document Type: Article

References (31)

1. Belldegrun A, Tsui KH, deKernion JB, Smith RB,. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. 1999; 17: 2868-2875.
2. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H,. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000; 75: 1236-1242.
3. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H,. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol. 2004; 171: 1066-1070.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-305.
5. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375: 2073-2081.
6. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011; 59: 543-552.
7. Tan HJ, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC,. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012; 307: 1629-1635.
8. Kowalczyk KJ, Choueiri TK, Hevelone ND, et al. Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007 [published online ahead of print March 4, 2013]. BJU Int. doi: 10.1111/j.1464-410X.2012.11776.x.
9. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P,. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes? J Urol. 2009; 181: 55-61; discussion 61-62.
10. Kim SP, Murad MH, Thompson RH, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012; 188: 51-57.
11. Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL,. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol. 2011; 174: 860-870.
12. Miller DC, Schonlau M, Litwin MS, Lai J, Saigal CS,. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer. 2008; 112: 511-520.
13. Klabunde CN, Harlan LC, Warren JL,. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care. 2006; 44: 921-928.
14. Klabunde CN, Potosky AL, Legler JM, Warren JL,. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258-67.
15. Dulabon LM, Lowrance WT, Russo P, Huang WC,. Trends in renal tumor surgery delivery within the United States. Cancer. 2010; 116: 2316-2321.
16. Chamie K, Saigal CS, Lai J, et al. Quality of care in patients with bladder cancer: a case report? Cancer. 2012; 118: 1412-1421.
17. Gu XS, Rosenbaum PR,. Comparison of multivariate matching methods: structures, distances, and algorithms. J Comput Graph Stat 1993; 2: 405-420.
18. Rosenbaum PR,. Observational studies. 2nd ed. New York, NY: Springer-Verlag; 2002.
19. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL,. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002; 40 (8 suppl): IV-19-25.
20. Kutikov A, Egleston BL, Wong YN, Uzzo RG,. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. 2010; 28: 311-317.
21. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006; 49: 466-465; discussion 75-77.
22. Group OLoEW. The Oxford 2011 Levels of Evidence. Oxford, UK: Oxford Centre for Evidence-Based Medicine; 2011.
23. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006; 7: 735-740.
24. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009; 182: 1271-1279.
25. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008; 179: 468-471; discussion 72-3.
26. Lane BR, Campbell SC, Demirjian S, Fergany AF,. Surgically-induced chronic kidney disease may be associated with lesser risk of progression and mortality than medical chronic kidney disease. J Urol. 2013; 189: 1649-1655.
27. Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010; 303: 959-966.
28. Canter D, Kutikov A, Sirohi M, et al. Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology. 2011; 77: 781-785.
29. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ,. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007; 297: 278-285.
30. Weight CJ, Miller DC, Campbell SC, Derweesh IH, Lane BR, Messing EM,. The management of a clinical T1b renal tumor in the presence of a normal contralateral kidney: the case for nephron-sparing surgery. J Urol. 2013; 189: 1198-1202.
31. Smaldone MC, Egleston B, Uzzo RG, Kutikov A,. Does partial nephrectomy result in a durable overall survival benefit in the medicare population? J Urol. 2012; 188: 2089-2094.